CHEST Physician
-
Navigating new ACR/CHEST guidelines for screening, monitoring, and treatment of SARD-ILD
Authors Jose R. Castellanos, MD; Anthony J. Esposito, MD; and Caroline Zhao, MD, discuss key strategies, including early screening with pulmonary function tests and high-resolution chest tomography, cautious glucocorticoid use, and personalized steroid-sparing treatment.
-
Mitigating risk of asthma emergencies during respiratory season
During respiratory illness season, asthma emergencies become a heightened concern, especially among children. With 10% of school-aged kids in the United States diagnosed with asthma, proactive measures including vaccination, updated asthma action plans and access to quick relief medications are critical.
-
RBC transfusion guidelines in critical care: Making the case for a restrictive approach
Author Angel Coz, MD, FCCP, makes the case for a restrictive RBC transfusion approach in critically ill adults based on a new guideline from CHEST.
-
Get to know incoming CHEST President, John A. Howington, MD, MBA, FCCP
Dr. Howington aims to continue advancing CHEST’s mission to fight lung disease while also addressing clinician burnout.
-
A visible impact
With the year drawing to a close, it’s the perfect time to look back on the accomplishments of 2024 and discuss what we hope to see in the coming year. Bob Musacchio, PhD, CEO of CHEST, and Bob De Marco, MD, FCCP, Chair of the CHEST Board of Advisors, reflect on CHEST philanthropy.
-
Council of Networks: Reflecting on the success of 2024
Council of Networks Chair, Margaret Pisani, MD, MPH, FCCP, provides a short recap of what the Networks accomplished this past year.
-
White ribbons around CHEST HQ raise awareness for lung cancer screening and early detection
During the month of November, CHEST displayed white ribbons around its headquarters in Glenview, Illinois, to raise awareness for lung cancer screening and early detection.
-
Top reads from the CHEST journal portfolio – December 2024
Read about nocturnal cardiac arrhythmias, spontaneous breathing trial protocols, and indeterminate lung nodules diagnosis.
-
Biomarker use in ARDS resulting from COVID-19 infection
There is renewed interest in the use of immunomodulatory therapies in patients with acute hypoxemic respiratory failure. Multiple investigations during the course of the pandemic demonstrated that dexamethasone administration improved mortality in patients with severe COVID-19.
-
Should napping be recommended as a health behavior?
The quest for an effective, inexpensive, and manageable intervention for sleep loss often leads to the question: What about naps? Author Sara C. Mednick, PhD lists the pros and cons.